Bregal Sagemount
12 May 2026
Ennov
650+
CUSTOMERS
use Ennov's software
500+
THOUSAND
users across 30 countries
25+
YEARS
of company development
Industry: Healthcare IT & Services
Year invested: 2026
Status: Current
Location: France
Investment Strategy: Flagship
Ennov is a global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies.
Founded and headquartered in Paris, Ennov provides a unified compliance platform that serves as a centralized system of record for global life sciences organizations. The platform supports the management of content and data across key domains, including Regulatory, Quality, Commercial, Clinical, and Pharmacovigilance. Its integrated architecture and unified data model enables faster deployment, improved user adoption, consistent compliance, and AI-driven efficiency across global operations.
"Regulatory and quality workflows in life sciences are becoming increasingly complex, while the cost of managing them across disconnected systems continues to rise. Olivier and his team have spent more than two decades building a mission-critical solution that enables customers to not only manage but optimize their processes to achieve better business outcomes. We believe this opportunity is only accelerating with Ennov’s new AI products, and we’re excited to support the Company in its next phase of growth. "
Gene Yoon
Managing Partner - Bregal Sagemount
Related